Form 4 for GH Guardant Health, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-01 · accession 0001977179-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-01 | GH | Chudova Darya | CTO | F - Tax | $102.14 | -12.3K | 17.4K | -41% | -$1.26M |
| DM | 2026-01-05 | 2026-01-01 | GH | Chudova Darya | CTO | M - OptEx | $0.00 | +22.7K | 20.7K | New | $0 |
| DM | 2026-01-05 | 2026-01-01 | GH | Chudova Darya | CTO | M - OptEx | $0.00 | -22.7K | 23.3K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-01 | F | D | 12,316 | $102.14 | 17,428 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2026-01-01 | M | A | 3,324 | $0.00 | 29,744 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-01 | M | A | 5,688 | $0.00 | 26,420 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-01 | M | A | 1,339 | $0.00 | 8,351 | D | — | — | |
| 5 | Common | Common Stock | 2026-01-01 | M | A | 10,714 | $0.00 | 19,065 | D | — | — | |
| 6 | Common | Common Stock | 2026-01-01 | M | A | 1,667 | $0.00 | 20,732 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2026-01-01 | M | D | 1,339 | $0.00 | 4,018 | D | $0.00 · — to — | 1,339 Common Stock | (F2) This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. (F3) Not applicable for Restricted Stock Units. |
| 8 | Derivative | Performance-Based Restricted Stock Units | 2026-01-01 | M | D | 10,714 | $0.00 | 0 | D | $0.00 · — to — | 10,714 Common Stock | (F4) This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. (F3) Not applicable for Restricted Stock Units. |
| 9 | Derivative | Restricted Stock Units | 2026-01-01 | M | D | 1,667 | $0.00 | 5,002 | D | $0.00 · — to — | 1,667 Common Stock | (F5) This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |
| 10 | Derivative | Performance-Based Restricted Stock Units | 2026-01-01 | M | D | 5,688 | $0.00 | 5,688 | D | $0.00 · — to — | 5,688 Common Stock | (F6) This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. (F3) Not applicable for Restricted Stock Units. |
| 11 | Derivative | Restricted Stock Units | 2026-01-01 | M | D | 3,324 | $0.00 | 23,268 | D | $0.00 · — to — | 3,324 Common Stock | (F7) This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |